<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05021146</url>
  </required_header>
  <id_info>
    <org_study_id>DO-221014-COP</org_study_id>
    <nct_id>NCT05021146</nct_id>
  </id_info>
  <brief_title>Essential Oil for Chronic Low Back Pain</brief_title>
  <acronym>ECAP</acronym>
  <official_title>Essential Oil for Chronic Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Buda Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>d≈çTERRA International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Buda Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The specific objective of this study is to assess the safety and clinical efficacy of a new&#xD;
      individualised spinal rehabilitation programme involving copaiba essential oil (CEO) therapy&#xD;
      compared to usual care for people with chronic low back pain. Research in complementary and&#xD;
      alternative medicine has increased over the last 15 years. As biochemical research shows,&#xD;
      these substances carry the ability to relieve pain and to reduce inflammation. In doing so,&#xD;
      it aims to:&#xD;
&#xD;
        1. Improve the health outcomes for individuals with chronic low back pain (CLBP) by&#xD;
           positively impacting their pain, disability, work capacity, physical activity and mental&#xD;
           health, and&#xD;
&#xD;
        2. Reduce the chronic health burden on society associated with treatment, sick leave,&#xD;
           rehabilitation, and involuntary retirement, by reducing health-related costs.&#xD;
&#xD;
      The primary clinical hypothesis is that patients with CLBP receiving individualised spinal&#xD;
      care and additional CEO topical treatment will have superior short- and long-term outcome&#xD;
      (defined by condition specific quality of life and general well-being) compared to usual&#xD;
      care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>6 months</time_frame>
    <description>Visual Analogue Scale measured on a scale 0-10 where the higher the number the worse the pain intensity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Function</measure>
    <time_frame>6 months</time_frame>
    <description>Oswestry Disability Index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Core Outcome Measures Index Back (COMI Back)</measure>
    <time_frame>6 months</time_frame>
    <description>A brief instrument for assessing the main outcomes of importance to patients with back problems (pain, function, symptom-specific well-being, quality of life, disability).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>6 months</time_frame>
    <description>EuroQoL-5D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological measurements- Fear Avoidance Beliefs</measure>
    <time_frame>6 months</time_frame>
    <description>Fear Avoidance Beliefs Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological measurements- Depression</measure>
    <time_frame>6 months</time_frame>
    <description>Beck Depression Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological measurements- Pain catastrophization:</measure>
    <time_frame>6 months</time_frame>
    <description>Pain Catastrophizing Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological measurements- Anxiety</measure>
    <time_frame>6 months</time_frame>
    <description>State-Trait Anxiety Inventory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal function</measure>
    <time_frame>6 months</time_frame>
    <description>Timed Up and Go (TUG) test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal active range of motion</measure>
    <time_frame>6 months</time_frame>
    <description>range of motion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global treatment outcome</measure>
    <time_frame>6 months</time_frame>
    <description>7- point Likert scale ( higher numbers representing worse the outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>6 months</time_frame>
    <description>5- point Likert scale (smaller number represent more satisfied patients)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Demand of treatment</measure>
    <time_frame>6 months</time_frame>
    <description>Pain medication and applied therapies after discharge</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Chronic Low-back Pain</condition>
  <arm_group>
    <arm_group_label>Standard care and CEO treatment with standard 20% concentration Copaiba oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care and CEO treatment with 40% concentration Copaiba oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care and placebo treatment with coconut oil</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care and topical essential copaiba oil</intervention_name>
    <description>All subjects will receive daily interdisciplinary - multimodular -treatment during their hospital stay including a daily 30 minute massage therapy. Both experimental groups and the placebo group patients continue to use topical treatment in the first half of the follow up period (90 days).</description>
    <arm_group_label>Standard care and CEO treatment with 40% concentration Copaiba oil</arm_group_label>
    <arm_group_label>Standard care and CEO treatment with standard 20% concentration Copaiba oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care and placebo treatment</intervention_name>
    <description>All subjects will receive daily interdisciplinary - multimodular -treatment during their hospital stay including a daily 30 minute massage therapy. Both experimental groups and the placebo group patients continue to use topical treatment in the first half of the follow up period (90 days).</description>
    <arm_group_label>standard care and placebo treatment with coconut oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>usual care</intervention_name>
    <description>All subjects will receive daily interdisciplinary - multimodular -treatment during their hospital stay.</description>
    <arm_group_label>Standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronic low back pain with or without irradiating pain (pain &gt; 3 months)&#xD;
&#xD;
          -  Low back pain is the dominant symptom, and Visual Analog Pain Scale (low back pain)&gt;4&#xD;
&#xD;
          -  Normal cognitive function, voluntary participation&#xD;
&#xD;
          -  Able to read and answer the questionnaires in English or Hungarian language&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous spinal surgery&#xD;
&#xD;
          -  Untreated metabolic bone disease&#xD;
&#xD;
          -  Active malignant disease&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Severe osteoporosis, fracture or posttraumatic deformity&#xD;
&#xD;
          -  Spinal infection&#xD;
&#xD;
          -  Neuromuscular disease&#xD;
&#xD;
          -  Autoimmune disease&#xD;
&#xD;
          -  Myelopathy&#xD;
&#xD;
          -  Congenital spinal deformity&#xD;
&#xD;
          -  Mental disorders&#xD;
&#xD;
          -  Severe sciatica&#xD;
&#xD;
          -  Severe spinal instability&#xD;
&#xD;
          -  Refusing the study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Pal Varga, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Buda Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aron Lazary, PhD</last_name>
    <phone>+3618877900</phone>
    <email>aron.lazary@bhc.hu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julia Szita, PhD</last_name>
    <phone>+3618877900</phone>
    <phone_ext>5670</phone_ext>
    <email>julia.szita@bhc.hu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Center for Spinal Disorders / Buda Health Center</name>
      <address>
        <city>Budapest</city>
        <zip>1126</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aron Lazary, PhD</last_name>
      <phone>+3618877900</phone>
      <email>aron.lazary@bhc.hu</email>
    </contact>
    <contact_backup>
      <last_name>Julia Szita, PhD</last_name>
      <phone>+3618877900</phone>
      <email>julia.szita@bhc.hu</email>
    </contact_backup>
    <investigator>
      <last_name>Peter Pal Varga, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julia Szita, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>August 18, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 25, 2021</study_first_posted>
  <last_update_submitted>October 7, 2021</last_update_submitted>
  <last_update_submitted_qc>October 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

